Offer - Urjas Oil for just ₹ 1 X
Chromet 1000 Tablet SR, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes.
The right dosage of Chromet 1000 Tablet SR depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Chromet 1000 Tablet SR include Stomach Upset, Difficulty urinating. Besides the aforementioned side effects, there are other adverse effects of Chromet 1000 Tablet SR as well, which are listed below. Such side effects of Chromet 1000 Tablet SR normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Chromet 1000 Tablet SR has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Chromet 1000 Tablet SR related warnings talks about Chromet 1000 Tablet SR's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Congestive Heart Failure (CHF), Anemia, Shock must refrain from the use of Chromet 1000 Tablet SR since this can cause severe adverse effects. The section on Chromet 1000 Tablet SR contraindications lists all such conditions.
Drug reaction of Chromet 1000 Tablet SR with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Chromet 1000 Tablet SR is considered safe while driving, and is addictive.
Chromet 1000 Tablet SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Chromet 1000 Tablet SR safe for pregnant women?
Pregnant women may get mild side effects from Chromet.
Is the use of Chromet 1000 Tablet SR safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Chromet. Immediately discontinue Chromet if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Chromet 1000 Tablet SR on the Kidneys?
There are no side effects of Chromet on the kidneys.
What is the effect of Chromet 1000 Tablet SR on the Liver?
Chromet is not harmful for the liver.
What is the effect of Chromet 1000 Tablet SR on the Heart?
You can take Chromet without any fear of damage to the heart.
Chromet 1000 Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Chromet 1000 Tablet SR unless your doctor advises you to do so -
Is this Chromet 1000 Tablet SR habit forming or addictive?
Chromet 1000 Tablet SR does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Chromet 1000 Tablet SR will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Chromet 1000 Tablet SR only as per medical advice.
Is it able to treat mental disorders?
No, the use of Chromet 1000 Tablet SR in mental disorders is not effective.
Interaction between Food and Chromet 1000 Tablet SR
There isn't any research available on the side effects of taking Chromet 1000 Tablet SR with food.
Interaction between Alcohol and Chromet 1000 Tablet SR
Consult your doctor before consuming alcohol while taking Chromet 1000 Tablet SR as it can have severe side effects.
Chromet helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Chromet is not approved for weight loss, this is an off-label use.
Lactic acidosis associated with Chromet treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Chromet induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Yes, Chromet can cause some sleep problems, especially insomnia. On the other hand, Chromet has proven to be useful for preventing sleep apnea. The exact relationship between Chromet and sleep problems is still not clear, and further studies are needed for a clearer understanding.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
Yes, Chromet commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Chromet with your meal and increase the dose gradually.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826